Immune therapy induces remission for many with ALL

Immune therapy induces remission for many with ALL
An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia patients who have run out of other options, according to research published in the Oct. 16 issue of the New England Journal of Medicine.

(HealthDay)—An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia (ALL) patients who have run out of other options, according to research published in the Oct. 16 issue of the New England Journal of Medicine.

The new therapy enlists the to target specific proteins on ALL , according to the researchers. A patient's T cells are genetically engineered to express chimeric antigen receptors which allow the T cells to recognize and destroy ALL cells. The modified cells are infused back into the patient's blood, where they multiply.

The researchers found that 27 of 30 children and adults with ALL went into full remission after receiving the genetically modified versions of their own . Most of the group has been followed for at least six months and for as long as two years. During that time, 19 remained in remission, while seven died after their cancer relapsed or progressed.

Senior researcher Stephan Grupp, M.D., Ph.D., of the Children's Hospital of Philadelphia and the University of Pennsylvania, told HealthDay that the major short-term risk is cytokine release syndrome. All of the patients in the current trial had cytokine release syndrome soon after treatment. "Patients can get quite sick," Grupp said, "but it's a manageable side effect."

Novartis, which partially funded this study, has licensed the particular technology used in the current study and is doing a larger trial at multiple U.S. hospitals; Grupp and some of his co-researchers are inventors of the technology.


Explore further

Personalized cellular therapy achieves complete remission in 90 percent of acute lymphoblastic leukemia patients studied

More information: Full Article
Full Text (subscription or payment may be required)
Journal information: New England Journal of Medicine

Copyright © 2014 HealthDay. All rights reserved.

Citation: Immune therapy induces remission for many with ALL (2014, October 16) retrieved 20 July 2019 from https://medicalxpress.com/news/2014-10-immune-therapy-remission.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more